TMAB
Dead / Abandoned — Abandoned — no statement of use filed (as of 09 Dec 2024)
What this means for you
This application is over — abandoned 09 Dec 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97090981
- Mark type
- Stylized text
- Filed
- 25 Oct 2021
- Published for opposition
- 13 Sept 2022
- Abandoned
- 09 Dec 2024
- Attorney of record
- Christine M. Baker
Goods and services
- Class 005 — Pharmaceuticals: Antibody therapeutic preparations for treating cancer and immunological diseases, pharmaceuticals for treating cancer and immunological diseases, and immuno-oncology pharmaceuticals and therapeutic preparations for treating cancer and immunological diseases, all the foregoing containing monoclonal antibodies
- Class 042 — Scientific and technological services: Research and development of antibody therapeutics and pharmaceuticals containing monoclonal antibodies for treating cancer and immunological diseases
Owner
- PPI Holdings, Inc., Rockville, MD, US
- PPI Holdings, Inc., Rockville, MD, US
Prosecution history
- 09 Dec 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 09 Dec 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 09 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 May 2024 — SOU EXTENSION 3 GRANTED
- 08 May 2024 — SOU EXTENSION 3 FILED
- 08 May 2024 — SOU TEAS EXTENSION RECEIVED
- 09 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Nov 2023 — SOU EXTENSION 2 GRANTED
- 07 Nov 2023 — SOU EXTENSION 2 FILED
- 07 Nov 2023 — SOU TEAS EXTENSION RECEIVED
- 09 May 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 May 2023 — SOU EXTENSION 1 GRANTED
- 05 May 2023 — SOU EXTENSION 1 FILED
- 05 May 2023 — SOU TEAS EXTENSION RECEIVED
- 08 Nov 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT